CN107698543A - A kind of preparation method of butyrolactone derivative - Google Patents

A kind of preparation method of butyrolactone derivative Download PDF

Info

Publication number
CN107698543A
CN107698543A CN201711126271.1A CN201711126271A CN107698543A CN 107698543 A CN107698543 A CN 107698543A CN 201711126271 A CN201711126271 A CN 201711126271A CN 107698543 A CN107698543 A CN 107698543A
Authority
CN
China
Prior art keywords
formula
compound
compound shown
obtains
spin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
CN201711126271.1A
Other languages
Chinese (zh)
Inventor
许良志
胡志刚
何大荣
杜小鹏
钱祝进
何勇
刘庄子
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Anhui Huasheng Medical Technology Co Ltd
Original Assignee
Anhui Huasheng Medical Technology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anhui Huasheng Medical Technology Co Ltd filed Critical Anhui Huasheng Medical Technology Co Ltd
Priority to CN201711126271.1A priority Critical patent/CN107698543A/en
Publication of CN107698543A publication Critical patent/CN107698543A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/32Oxygen atoms
    • C07D307/33Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24Oxygen or sulfur atoms
    • C07D207/262-Pyrrolidones
    • C07D207/2632-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms
    • C07D207/272-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention discloses a kind of preparation method of butyrolactone derivative, comprise the following steps:(1) compound of formula (II) is substituted with propyl group grignard reagent, obtains the compound of formula (III);(2) compound of formula (III) is removed into benzyl protection, obtains the compound of formula (IV);(3) it is cyano group by the compound substituted hydroxy of formula (IV), obtains the compound of formula (V);(4) by the compound removing tert-butyl group protection of formula (V), the compound of acquisition formula (VI);(5) compound of formula (VI) is reduced into carboxyl, obtains the compound of formula (VII);(6) compound of formula (VII) is hydrolyzed into cyano group in the basic conditions, obtains the carboxylic acid derivates of formula (VIII), then the butyrolactone derivative of acquisition formula (I) is reacted through dehydration condensation.It is an advantage of the current invention that stereoselectivity is good, easy to operate, total recovery is higher, is adapted to amplification production.Synthetic route is as follows:

Description

A kind of preparation method of butyrolactone derivative
Technical field
The present invention relates to organic synthesis technical field, is more particularly to a kind of preparation method of butyrolactone derivative.
Background technology
Butyrolactone derivative shown in lower formula (I) is new antiepileptic medicine Bu Waxitan (Brivaracetam) synthesis Key intermediate.
At present, has the more document reports synthetic method of above-mentioned butyrolactone derivative, for example, patent document Following synthetic method is reported in WO2016/191435, wherein using R- epoxychloropropane as raw material, is contracted with diethyl malonate Close, then with ethyl phosphonium bromide reactive magnesium, last decarboxylation obtains key intermediate butyrolactone derivative, but its cost is costly.
And for example, document Hughes, G. et al., J.Am.Chem.Soc.2003, report is with positive penta in 125,11253-11258 Aldehyde is raw material, through cyclization, reduction, most above-mentioned butyrolactone derivative is obtained through asymmetric reduction afterwards, wherein using valuable chirality Catalyst and part, and it is difficult to keep high chiral purity.And document Rudroff, F. et al., Adv.Synth.Catal.2007, report uses expensive biology enzyme using 1- amylenes as raw material after cyclization in 349,1436-1444 Catalyst, oxidation ring expansion obtain above-mentioned butyrolactone derivative.
Therefore, find that a kind of step is simple, production cost is low, regioselectivity is strong, the butyrolactone derivative of high income Preparation method is the current technical problem for being badly in need of solving.
The content of the invention
The technical problems to be solved by the invention are the provision of a kind of preparation method of new butyrolactone derivative.
The present invention is that solve above-mentioned technical problem by the following technical programs:
A kind of preparation method of butyrolactone derivative, comprises the following steps:
(1) compound shown in formula (II) is substituted with propyl group grignard reagent, obtains the compound shown in formula (III);
(2) compound shown in formula (III) is removed into benzyl protection, obtains the compound shown in formula (IV);
(3) it is cyano group by the compound substituted hydroxy shown in formula (IV), obtains the compound shown in formula (V);
(4) by the compound removing tert-butyl group protection shown in formula (V), the compound shown in formula (VI) is obtained;
(5) compound shown in formula (VI) is reduced into carboxyl, obtains the compound shown in formula (VII);
(6) compound shown in formula (VII) is hydrolyzed into cyano group in the basic conditions, obtains the carboxylic acid shown in formula (VIII) and spread out Biology, then react the butyrolactone derivative shown in acquisition formula (I) through dehydration condensation;
Preferably, the preparation method comprises the following steps:
(1) anhydrous zinc chloride is dissolved in tetrahydrofuran, the compound shown in addition formula (II), 20~30 DEG C of stirrings 5~ 0 DEG C is cooled to after 15min, adds after propyl group grignard reagent and is stirred 2~4 hours at 0 DEG C, terminating reaction, has been washed out Machine phase, solvent is spin-dried for, obtains the compound shown in formula (III);
(2) compound shown in formula (III) is dissolved in methanol, addition palladium carbon, normal pressure hydrogenation 2~5 hours, then mistake Filter, be spin-dried for filtrate, again through column chromatography, obtaining the compound shown in formula (IV);
(3) compound shown in formula (IV) is dissolved in dichloromethane, adds N, N- diisopropyl ethyl amines and methyl sulphur Acyl chlorides, after 20~30 DEG C are stirred 1~3 hour, progress first time washing, drying are simultaneously spin-dried for solvent, are re-dissolved in dioxane, add Enter TBAB and potassium cyanide, 20~30 DEG C are stirred 36~60 hours, and second of washing is carried out after dilution, dries and is spin-dried for Solvent, obtain the compound shown in formula (V);
(4) compound shown in formula (V) is dissolved in dichloromethane, then adds trifluoroacetic acid, 20~30 DEG C of stirrings 1~ 4 hours, solvent is spin-dried at a temperature of no more than 40 DEG C, then through column chromatography, obtain the compound shown in formula (VI);
(5) compound shown in formula (VI) is dissolved in tetrahydrofuran and is cooled to 0 DEG C, addition tetrahydrofuran borane Thing, 20~30 DEG C be stirred overnight after be added dropwise aqueous hydrochloric acid solution, stir 0.5~2 hour, wash, dry after dilution and be spin-dried for solvent, Compound shown in acquisition formula (VII);
(6) compound shown in formula (VII) is suspended in the mixture of second alcohol and water, adds NaOH, backflow 10~30 After hour, 0 degree Celsius is cooled to, is spin-dried for after being adjusted to neutrality, obtains the carboxylic acid derivates shown in formula (VIII);By formula (VIII) institute The carboxylic acid derivates shown are dissolved in toluene, add p-methyl benzenesulfonic acid, and backflow overnight, is washed out, is spin-dried for solvent, depressurizes steaming again Evaporate, obtain the butyrolactone derivative shown in formula (I).
Preferably, in step (1), propyl group grignard reagent is propyl group magnesium chloride, and/or
The molar equivalent ratio of compound and propyl group magnesium chloride shown in formula (II) is 1:1~2.
Preferably, in step (1), the reagent of terminating reaction is saturated aqueous ammonium chloride;And/or
The process of washing is successively with saturated sodium bicarbonate aqueous solution, saturated common salt water washing.
Preferably, in step (2), the mass ratio of compound and palladium carbon shown in formula (III) is 15~20:1;The palladium Carbon is 10% palladium carbon.
Preferably, in step (3), the compound shown in formula (IV):N, N- diisopropyl ethyl amine:Methylsufonyl chloride: TBAB:The mass ratio of potassium cyanide is 40~55:30~45:25~35:1:15~25;And/or
The process of washing is successively with aqueous hydrochloric acid solution, saturated sodium bicarbonate aqueous solution and saturated common salt washing for the first time Wash;And/or
The process of dilution is to be diluted with methyl tertiary butyl ether(MTBE);And/or
The process of second of washing is successively with aqueous hydrochloric acid solution, saturated sodium bicarbonate aqueous solution and saturated common salt washing Wash.
Preferably, in step (4), 1~1.5mL trifluoroacetic acids are added in the compound shown in per 1g formulas (V).
Preferably, in step (5), 15~40mL tetrahydrofuran borine networks are added in the compound shown in per 1g formulas (VI) Compound;And/or
The process of dilution is to be diluted with methyl tertiary butyl ether(MTBE);And/or
The process of washing is to use aqueous hydrochloric acid solution, saturated sodium bicarbonate aqueous solution and saturated common salt water washing successively.
Preferably, in step (6), the mass ratio of compound and NaOH shown in formula (VII) is 4~9:1;And/or
The volume ratio of ethanol and water is 2~4 in the mixture of second alcohol and water:1;
The process of washing is to use water, saturated sodium bicarbonate aqueous solution and saturated common salt water washing successively.
Purposes of the butyrolactone derivative that preparation method of the present invention obtains in Bu Waxitan is prepared.
The present invention has advantages below compared with prior art:A kind of brand-new butyrolactone derivative preparation method is provided, its Stereoselectivity is good, easy to operate, and total recovery is higher, is adapted to amplification production.
Embodiment
Embodiments of the invention are elaborated below, the present embodiment is carried out lower premised on technical solution of the present invention Implement, give detailed embodiment and specific operating process, but protection scope of the present invention is not limited to following implementation Example.
The preparation of compound shown in the formula of embodiment 1 (II)
Synthetic route is as follows:
(1) L- glyceric acid (138g) and DMAP (10g) are dissolved in THF (2L), are cooled to 0 degree Celsius, are added portionwise Boc2O (872g), after subsequent 0 degree Celsius is stirred 24 hours, reaction solution is spin-dried for, it is dry 3 times with toluene band.Residue is re-dissolved in In THF (1L), potassium carbonate (276g) is added, stirring at normal temperature is after 1 hour, adds benzyl chloride (190g), then stirring at normal temperature 48 hours, adds Enter after reaction is quenched in methanol (50mL), reaction solution is poured into 1L water, separates organic phase, then aqueous phase is extracted with the tertiary ether of first.Merge After organic phase, with saturated common salt water washing 2 times, organic phase is spin-dried for, residue cross post obtain grease II-1 (118g, 47%).High resolution mass spectrum (ESI+):C14H21O4+ theoretical values 253.1434, measured value 253.1428.
(2) above-mentioned oily compound II-1 (63.0g, 250mmol) is dissolved in dichloromethane (1.5L), adds 2,6- diformazans Yl pyridines (40.0g, 375mmol), are cooled to 0 DEG C, and trifluoromethanesulfanhydride anhydride (98.7g, 350mmol) is slowly added dropwise, and are added dropwise within 1 hour Finish, then reacted 1 hour at 0 DEG C.Reaction solution uses 1N aqueous hydrochloric acid solutions (1L × 2) and saturated sodium-chloride sodium chloride water successively Solution washing (1L × 2) washing, anhydrous magnesium sulfate are dried, and are concentrated under reduced pressure into the dry compound (91.6g) obtained shown in formula (II), Yield is 95%.High resolution mass spectrum (ESI+):C15H20F3O6S+ theoretical values 385.0927, measured value 385.0921.
The synthesis of butyrolactone derivative shown in the formula of embodiment 2 (I)
Synthetic route is as follows:
(1) anhydrous zinc chloride (0.17g, 0.025 equivalent) is dissolved in 300mL tetrahydrofurans (THF), adds embodiment 1 Compound (19.2g, 1 equivalent) shown in the formula (II) of preparation, 20~30 DEG C stirring 10min after be cooled to 0 DEG C, add propyl group Magnesium chloride (70mL, 1.4 equivalents, concentration:1M THF solutions), stirred 3 hours at 0 DEG C, 100mL saturated aqueous ammonium chlorides are added dropwise Terminating reaction, organic phase with 150mL saturated sodium bicarbonate aqueous solutions, 150mL saturated common salt water washings, are spin-dried for solvent, obtained successively Obtain the compound (12.4g, yield 89%) shown in formula (III).High resolution mass spectrum (ESI+):C17H27O3+ theoretical values 279.1955 measured value 279.1949.
(2) compound (9.3g, 1 equivalent) shown in formula (III) is dissolved in 100mL methanol, adds the palladiums of 0.5g 10% Carbon, normal pressure hydrogenation 3 hours, then filtering reacting liquid, is spin-dried for filtrate, obtains crude compound, then column chromatography obtains formula (IV) institute The compound (5.7g, yield 90%) shown.High resolution mass spectrum (ESI+):C10H21O3+ theoretical values 189.1485, measured value are 189.1477。
(3) compound (4.7g, 1 equivalent) shown in formula (IV) is dissolved in 80mL dichloromethane, adds N, N- diisopropyls Base ethylamine (3.9g, 1.2 equivalents) and methylsufonyl chloride (3.1g, 1.1 equivalents), after 20~30 DEG C are stirred 2 hours, use successively 40mL 1N (mol/L) aqueous hydrochloric acid solution, 40mL saturated sodium bicarbonate aqueous solutions and 40mL saturated aqueous common salts wash for the first time Wash, dry and be spin-dried for solvent, then residue is dissolved in 50mL dioxane, add TBAB (100mg) and cyaniding Potassium (1.95g, 1.2 equivalents), 20~30 DEG C are stirred 48 hours, then dilute reaction solution with 100mL methyl tertiary butyl ether(MTBE)s, then according to It is secondary to carry out second of washing with 75mL 1N aqueous hydrochloric acid solutions, 75mL saturated sodium bicarbonate aqueous solutions and 75mL saturated aqueous common salts, do It is dry and be spin-dried for solvent, obtain the compound shown in formula (V).High resolution mass spectrum (ESI+):C11H20NO2+ theoretical values 198.1489 measured value 198.1481.
(4) compound shown in 8g formulas (V) is dissolved in 80mL dichloromethane, addition 10mL trifluoroacetic acids, 20~30 DEG C Stirring 2 hours, solvent is spin-dried at a temperature of no more than 40 DEG C, then residue is obtained into the change shown in formula (VI) through column chromatography Compound (1.1g, yield 31%).High resolution mass spectrum (ESI+):C7H10NO2- theoretical values 140.0717, measured value are 140.0719。
(5) compound (10g, 1 equivalent) shown in formula (VI) is dissolved in 200mL tetrahydrofurans and is cooled to 0 DEG C, addition 280mL tetrahydrofurans borane complex (1M tetrahydrofurans, 4 equivalents), 20~30 DEG C be stirred overnight after be added dropwise 100mL 1N hydrochloric acid The aqueous solution, stir 1 hour, after being diluted with 500mL methyl tertiary butyl ether(MTBE)s, successively with 250mL 1N aqueous hydrochloric acid solutions, 250mL saturations Sodium bicarbonate aqueous solution and 250mL saturated common salt water washings, dry and be spin-dried for solvent, obtain the compound shown in formula (VII) (7.7g, yield 85%).High resolution mass spectrum (ESI+):C7H14NO+ theoretical values 128.1070, measured value 128.1063.
(6) compound (20.3g, 1 equivalent) shown in formula (VII) is suspended in the mixture of 30mL ethanol and 10mL water In, NaOH (3g) is added, after flowing back 20 hours, 0 degree Celsius is cooled to, is spin-dried for after being adjusted to neutrality with 1N hydrochloric acid, obtains intermediate The crude product of carboxylic acid derivates shown in formula (VIII).This crude product is directly suspended in 300mL toluene, adds p-methyl benzenesulfonic acid Reaction solution overnight, is used 100mL water, 100mL saturated sodium bicarbonate aqueous solutions and 100mL by (41.3g, 1.5 equivalents), backflow successively Saturated common salt water washing, it is spin-dried for solvent and obtains crude compound, then is evaporated under reduced pressure to obtain the butyrolactone derivative shown in formula (I) (12g, yield 59%).High resolution mass spectrum (ESI+):C7H13O2+ theoretical values 129.0910, measured value 129.0903.
The synthesis of butyrolactone derivative shown in the formula of embodiment 3 (I)
(1) anhydrous zinc chloride (0.17g, 0.025 equivalent) is dissolved in 300mL tetrahydrofurans (THF), adds embodiment 1 Compound (19.2g, 1 equivalent) shown in the formula (II) of preparation, 20~30 DEG C stirring 5min after be cooled to 0 DEG C, add propyl group Magnesium chloride (70mL, 1 equivalent, concentration:1M THF solutions), stirred 2 hours at 0 DEG C, it is whole that 100mL saturated aqueous ammonium chlorides are added dropwise Only react, organic phase with 150mL saturated sodium bicarbonate aqueous solutions, 150mL saturated common salt water washings, is spin-dried for solvent successively, obtains Compound (9.2g, yield 78%) shown in formula (III).High resolution mass spectrum (ESI+):C17H27O3+ theoretical values 279.1955 measured value 279.1949.
(2) compound (7.5g, 1 equivalent) shown in formula (III) is dissolved in 100mL methanol, adds the palladiums of 0.5g 10% Carbon, normal pressure hydrogenation 2 hours, then filtering reacting liquid, is spin-dried for filtrate, obtains crude compound, then column chromatography obtains formula (IV) institute The compound (4.1g, yield 80%) shown.High resolution mass spectrum (ESI+):C10H21O3+ theoretical values 189.1485, measured value are 189.1477。
(3) compound (4g) shown in formula (IV) is dissolved in 80mL dichloromethane, adds N, N- diisopropyl ethyl amines (3g) and methylsufonyl chloride (2.5g), 20~30 DEG C stirring 1 hour after, successively with 40mL 1N (mol/L) aqueous hydrochloric acid solution, 40mL saturated sodium bicarbonate aqueous solutions and 40mL saturated aqueous common salts carry out first time washing, dry and are simultaneously spin-dried for solvent, then by remnants Thing is dissolved in 50mL dioxane, adds TBAB (100mg) and potassium cyanide (1.5g), and 20~30 DEG C of stirrings 36 are small When, then reaction solution is diluted with 100mL methyl tertiary butyl ether(MTBE)s, then successively with 75mL 1N aqueous hydrochloric acid solutions, 75mL unsaturated carbonates Hydrogen sodium water solution and 75mL saturated aqueous common salts carry out second and washed, and dry and are spin-dried for solvent, obtain the chemical combination shown in formula (V) Thing.High resolution mass spectrum (ESI+):C11H20NO2+ theoretical values 198.1489, measured value 198.1481.
(4) compound shown in 8g formulas (V) is dissolved in 80mL dichloromethane, adds 8mL trifluoroacetic acids, 20~30 DEG C are stirred Mix 1 hour, solvent is spin-dried at a temperature of no more than 40 DEG C, then residue is obtained into the chemical combination shown in formula (VI) through column chromatography Thing (0.8g, yield 27%).High resolution mass spectrum (ESI+):C7H10NO2- theoretical values 140.0717, measured value are 140.0719。
(5) compound (10g, 1 equivalent) shown in formula (VI) is dissolved in 200mL tetrahydrofurans and is cooled to 0 DEG C, addition 150mL tetrahydrofurans borane complex (1M tetrahydrofurans, 4 equivalents), 20~30 DEG C be stirred overnight after be added dropwise 100mL 1N hydrochloric acid The aqueous solution, stir 0.5 hour, after being diluted with 500mL methyl tertiary butyl ether(MTBE)s, satisfied successively with 250mL 1N aqueous hydrochloric acid solutions, 250mL With sodium bicarbonate aqueous solution and 250mL saturated common salt water washings, dry and be spin-dried for solvent, obtain the compound shown in formula (VII) (5.4g, yield 76%).High resolution mass spectrum (ESI+):C7H14NO+ theoretical values 128.1070, measured value 128.1063.
(6) compound (12g) shown in formula (VII) is suspended in the mixture of 20mL ethanol and 10mL water, added NaOH (3g), after flowing back 10 hours, 0 degree Celsius is cooled to, is spin-dried for after being adjusted to neutrality with 1N hydrochloric acid, obtains intermediate formula (VIII) The crude product of shown carboxylic acid derivates.This crude product is directly suspended in 300mL toluene, and addition p-methyl benzenesulfonic acid (41.3g, 1.5 Equivalent), reaction solution overnight, is used 100mL water, 100mL saturated sodium bicarbonate aqueous solutions and 100mL saturated aqueous common salts by backflow successively Washing, is spin-dried for solvent and obtains crude compound, then be evaporated under reduced pressure to obtain butyrolactone derivative (8g, the yield shown in formula (I) 43%).High resolution mass spectrum (ESI+):C7H13O2+ theoretical values 129.0910, measured value 129.0903.
The synthesis of butyrolactone derivative shown in the formula of embodiment 4 (I)
(1) anhydrous zinc chloride (0.17g, 0.025 equivalent) is dissolved in 300mL tetrahydrofurans (THF), adds embodiment 1 Compound (19.2g, 1 equivalent) shown in the formula (II) of preparation, 20~30 DEG C stirring 15min after be cooled to 0 DEG C, add propyl group Magnesium chloride (70mL, 2 equivalents, concentration:1M THF solutions), stirred 4 hours at 0 DEG C, it is whole that 100mL saturated aqueous ammonium chlorides are added dropwise Only react, organic phase with 150mL saturated sodium bicarbonate aqueous solutions, 150mL saturated common salt water washings, is spin-dried for solvent successively, obtains Compound (10.1g, yield 81%) shown in formula (III).High resolution mass spectrum (ESI+):C17H27O3+ theoretical values 279.1955 measured value 279.1949.
(2) compound (10g, 1 equivalent) shown in formula (III) is dissolved in 100mL methanol, adds the palladiums of 0.5g 10% Carbon, normal pressure hydrogenation 5 hours, then filtering reacting liquid, is spin-dried for filtrate, obtains crude compound, then column chromatography obtains formula (IV) institute The compound (5.2g, yield 83%) shown.High resolution mass spectrum (ESI+):C10H21O3+ theoretical values 189.1485, measured value are 189.1477。
(3) compound (5.5g) shown in formula (IV) is dissolved in 80mL dichloromethane, adds N, N- diisopropyl ethyls Amine (4.5g) and methylsufonyl chloride (3.5g), it is water-soluble with 40mL 1N (mol/L) hydrochloric acid successively after 20~30 DEG C are stirred 3 hours Liquid, 40mL saturated sodium bicarbonate aqueous solutions and 40mL saturated aqueous common salts carry out first time washing, dry and are spin-dried for solvent, then will be residual Excess is dissolved in 50mL dioxane, adds TBAB (100mg) and potassium cyanide (2.5g), and 20~30 DEG C of stirrings 60 are small When, then reaction solution is diluted with 100mL methyl tertiary butyl ether(MTBE)s, then successively with 75mL 1N aqueous hydrochloric acid solutions, 75mL unsaturated carbonates Hydrogen sodium water solution and 75mL saturated aqueous common salts carry out second and washed, and dry and are spin-dried for solvent, obtain the chemical combination shown in formula (V) Thing.High resolution mass spectrum (ESI+):C11H20NO2+ theoretical values 198.1489, measured value 198.1481.
(4) compound shown in 8g formulas (V) is dissolved in 80mL dichloromethane, addition 12mL trifluoroacetic acids, 20~30 DEG C Stirring 4 hours, solvent is spin-dried at a temperature of no more than 40 DEG C, then residue is obtained into the change shown in formula (VI) through column chromatography Compound (1.0g, yield 28%).High resolution mass spectrum (ESI+):C7H10NO2- theoretical values 140.0717, measured value are 140.0719。
(5) compound (10g, 1 equivalent) shown in formula (VI) is dissolved in 200mL tetrahydrofurans and is cooled to 0 DEG C, addition 400mL tetrahydrofurans borane complex (1M tetrahydrofurans, 4 equivalents), 20~30 DEG C be stirred overnight after be added dropwise 100mL 1N hydrochloric acid The aqueous solution, stir 2 hours, after being diluted with 500mL methyl tertiary butyl ether(MTBE)s, successively with 250mL 1N aqueous hydrochloric acid solutions, 250mL saturations Sodium bicarbonate aqueous solution and 250mL saturated common salt water washings, dry and be spin-dried for solvent, obtain the compound shown in formula (VII) (7.1g, yield 79%).High resolution mass spectrum (ESI+):C7H14NO+ theoretical values 128.1070, measured value 128.1063.
(6) compound (27g) shown in formula (VII) is suspended in the mixture of 40mL ethanol and 10mL water, added NaOH (3g), after flowing back 30 hours, 0 degree Celsius is cooled to, is spin-dried for after being adjusted to neutrality with 1N hydrochloric acid, obtains intermediate formula (VIII) The crude product of shown carboxylic acid derivates.This crude product is directly suspended in 300mL toluene, and addition p-methyl benzenesulfonic acid (41.3g, 1.5 Equivalent), reaction solution overnight, is used 100mL water, 100mL saturated sodium bicarbonate aqueous solutions and 100mL saturated aqueous common salts by backflow successively Washing, is spin-dried for solvent and obtains crude compound, then be evaporated under reduced pressure to obtain butyrolactone derivative (10.5g, the yield shown in formula (I) 52%).High resolution mass spectrum (ESI+):C7H13O2+ theoretical values 129.0910, measured value 129.0903.
The butyrolactone derivative that embodiment 2-4 is obtained can be used for preparing Bu Waxitan.
The foregoing is merely illustrative of the preferred embodiments of the present invention, is not intended to limit the invention, all essences in the present invention All any modification, equivalent and improvement made within refreshing and principle etc., should be included in the scope of the protection.

Claims (10)

1. a kind of preparation method of butyrolactone derivative, it is characterised in that comprise the following steps:
(1) compound shown in formula (II) is substituted with propyl group grignard reagent, obtains the compound shown in formula (III);
(2) compound shown in formula (III) is removed into benzyl protection, obtains the compound shown in formula (IV);
(3) it is cyano group by the compound substituted hydroxy shown in formula (IV), obtains the compound shown in formula (V);
(4) by the compound removing tert-butyl group protection shown in formula (V), the compound shown in formula (VI) is obtained;
(5) compound shown in formula (VI) is reduced into carboxyl, obtains the compound shown in formula (VII);
(6) compound shown in formula (VII) is hydrolyzed into cyano group in the basic conditions, obtains the carboxylic acid shown in formula (VIII) and derive Thing, then react the butyrolactone derivative shown in acquisition formula (I) through dehydration condensation;
2. the preparation method of butyrolactone derivative according to claim 1, it is characterised in that comprise the following steps:
(1) anhydrous zinc chloride is dissolved in tetrahydrofuran, adds the compound shown in formula (II), 20~30 DEG C of 5~15min of stirring After be cooled to 0 DEG C, add after propyl group grignard reagent and stirred 2~4 hours at 0 DEG C, terminating reaction, be washed out organic phase, Solvent is spin-dried for, obtains the compound shown in formula (III);
(2) compound shown in formula (III) is dissolved in methanol, addition palladium carbon, normal pressure hydrogenation 2~5 hours, then filter, It is spin-dried for filtrate, again through column chromatography, obtains the compound shown in formula (IV);
(3) compound shown in formula (IV) is dissolved in dichloromethane, adds N, N- diisopropyl ethyl amines and methylsufonyl chloride, After 20~30 DEG C are stirred 1~3 hour, progress first time washing, drying are simultaneously spin-dried for solvent, are re-dissolved in dioxane, add four Butylammonium bromide and potassium cyanide, 20~30 DEG C are stirred 36~60 hours, and second of washing is carried out after dilution, dries and is spin-dried for molten Agent, obtain the compound shown in formula (V);
(4) compound shown in formula (V) is dissolved in dichloromethane, then adds trifluoroacetic acid, 20~30 DEG C of stirrings 1~4 are small When, solvent is spin-dried at a temperature of no more than 40 DEG C, then through column chromatography, obtain the compound shown in formula (VI);
(5) compound shown in formula (VI) is dissolved in tetrahydrofuran and is cooled to 0 DEG C, add tetrahydrofuran borane complex, 20~30 DEG C be stirred overnight after be added dropwise aqueous hydrochloric acid solution, stir 0.5~2 hour, washed after dilution, dry and be spin-dried for solvent, obtained Obtain the compound shown in formula (VII);
(6) compound shown in formula (VII) is suspended in the mixture of second alcohol and water, adds NaOH, flowed back 10~30 hours Afterwards, 0 degree Celsius is cooled to, is spin-dried for after being adjusted to neutrality, obtains the carboxylic acid derivates shown in formula (VIII);By shown in formula (VIII) Carboxylic acid derivates are dissolved in toluene, add p-methyl benzenesulfonic acid, and backflow overnight, is washed out, is spin-dried for solvent, is evaporated under reduced pressure again, obtain Obtain the butyrolactone derivative shown in formula (I).
3. the preparation method of butyrolactone derivative according to claim 1 or 2, it is characterised in that in step (1), institute It is propyl group magnesium chloride to state propyl group grignard reagent.
4. the preparation method of butyrolactone derivative according to claim 2, it is characterised in that in step (1), the end The reagent only reacted is saturated aqueous ammonium chloride;And/or
The process of the washing is successively with saturated sodium bicarbonate aqueous solution, saturated common salt water washing.
5. the preparation method of butyrolactone derivative according to claim 2, it is characterised in that in step (2), formula (III) mass ratio of compound and palladium carbon shown in is 15~20:1;The palladium carbon is 10% palladium carbon.
6. the preparation method of butyrolactone derivative according to claim 2, it is characterised in that in step (3), formula (IV) Shown compound:N, N- diisopropyl ethyl amine:Methylsufonyl chloride:TBAB:The mass ratio of potassium cyanide be 40~ 55:30~45:25~35:1:15~25;And/or
The process of the first time washing is successively with aqueous hydrochloric acid solution, saturated sodium bicarbonate aqueous solution and saturated common salt washing Wash;And/or
The process of the dilution is to be diluted with methyl tertiary butyl ether(MTBE);And/or
The process of second of washing is successively with aqueous hydrochloric acid solution, saturated sodium bicarbonate aqueous solution and saturated common salt washing Wash.
7. the preparation method of butyrolactone derivative according to claim 2, it is characterised in that in step (4), per 1g formulas (V) 1~1.5mL trifluoroacetic acids are added in the compound shown in.
8. the preparation method of butyrolactone derivative according to claim 2, it is characterised in that in step (5), per 1g formulas (VI) 15~40mL tetrahydrofuran borane complexes are added in the compound shown in;And/or
The process of the dilution is to be diluted with methyl tertiary butyl ether(MTBE);And/or
The process of the washing is to use aqueous hydrochloric acid solution, saturated sodium bicarbonate aqueous solution and saturated common salt water washing successively.
9. the preparation method of butyrolactone derivative according to claim 2, it is characterised in that in step (6), formula (VII) mass ratio of compound and NaOH shown in is 4~9:1;And/or
The volume ratio of ethanol and water is 2~4 in the mixture of the second alcohol and water:1;
The process of the washing is to use water, saturated sodium bicarbonate aqueous solution and saturated common salt water washing successively.
10. the butyrolactone derivative that the preparation method any one of claim 1 to 9 obtains is in Bu Waxitan is prepared Purposes.
CN201711126271.1A 2017-11-14 2017-11-14 A kind of preparation method of butyrolactone derivative Withdrawn CN107698543A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201711126271.1A CN107698543A (en) 2017-11-14 2017-11-14 A kind of preparation method of butyrolactone derivative

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201711126271.1A CN107698543A (en) 2017-11-14 2017-11-14 A kind of preparation method of butyrolactone derivative

Publications (1)

Publication Number Publication Date
CN107698543A true CN107698543A (en) 2018-02-16

Family

ID=61179669

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201711126271.1A Withdrawn CN107698543A (en) 2017-11-14 2017-11-14 A kind of preparation method of butyrolactone derivative

Country Status (1)

Country Link
CN (1) CN107698543A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT201800006320A1 (en) * 2018-06-14 2019-12-14 PROCESS FOR THE ASYMMETRIC SYNTHESIS OF (R) -4-PROPYLDIHYDROFURAN-2 (3H) -ONE
CN111675643A (en) * 2020-06-15 2020-09-18 浙江天宇药业股份有限公司 Preparation method of brivaracetam
CN115197178A (en) * 2022-08-24 2022-10-18 四川诺非特生物药业科技有限公司 Synthesis method of brivaracetam key intermediate

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009155280A (en) * 2007-12-27 2009-07-16 Mitsubishi Rayon Co Ltd METHOD FOR PRODUCING gamma-BUTYROLACTONE COMPOUND
US20100305352A1 (en) * 2007-09-24 2010-12-02 Bernhard Breit Method for the production of optically active alpha alkyl carbonyl compounds
CN105837535A (en) * 2016-04-06 2016-08-10 成都拿盛科技有限公司 Synthesis method of substituted chiral gamma-butanolide

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100305352A1 (en) * 2007-09-24 2010-12-02 Bernhard Breit Method for the production of optically active alpha alkyl carbonyl compounds
JP2009155280A (en) * 2007-12-27 2009-07-16 Mitsubishi Rayon Co Ltd METHOD FOR PRODUCING gamma-BUTYROLACTONE COMPOUND
CN105837535A (en) * 2016-04-06 2016-08-10 成都拿盛科技有限公司 Synthesis method of substituted chiral gamma-butanolide

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
FADEL, ANTOINE ET AL.,: "Optically active cyclopentanones from chiral malonates: a versatile approach to (+)-α- and (-)-β-cuparenones", 《SYNLETT》 *
ZHI-GANG JIAO ET AL.: "β N-O Turns and Helices Induced by b2-Aminoxy Peptides: Synthesis and Conformational Studies", 《CHEMISTRY - AN ASIAN JOURNAL》 *

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT201800006320A1 (en) * 2018-06-14 2019-12-14 PROCESS FOR THE ASYMMETRIC SYNTHESIS OF (R) -4-PROPYLDIHYDROFURAN-2 (3H) -ONE
WO2019239341A1 (en) * 2018-06-14 2019-12-19 Procos S.P.A. Process for asymmetric synthesis of (r)-4-propyldihydrofuran-2 (3h)-one
CN111675643A (en) * 2020-06-15 2020-09-18 浙江天宇药业股份有限公司 Preparation method of brivaracetam
CN111675643B (en) * 2020-06-15 2021-10-26 浙江天宇药业股份有限公司 Preparation method of brivaracetam
CN115197178A (en) * 2022-08-24 2022-10-18 四川诺非特生物药业科技有限公司 Synthesis method of brivaracetam key intermediate
CN115197178B (en) * 2022-08-24 2024-04-26 四川诺非特生物药业科技有限公司 Synthesis method of brivaracetam key intermediate

Similar Documents

Publication Publication Date Title
CN106432030B (en) A kind of preparation method of Bu Waxitan
CN107698543A (en) A kind of preparation method of butyrolactone derivative
CN101712603B (en) Method for preparing halogenated methyl-benzaldehyde by Grignard reaction
CN107652254A (en) A kind of method for preparing butyrolactone derivative
CN110305010B (en) Preparation method of 2, 5-dimethylphenylacetic acid
CN105728046A (en) Ruthenium metallic olefin metathesis catalyst and preparation and application methods thereof
CN112851646A (en) Preparation method of Tegolrazan
TW202030177A (en) Processes to produce elagolix
CN105111197A (en) Synthesis methods of raltitrexed
CN113683651A (en) Preparation method of GalNAc intermediate
CN109761913A (en) A kind of method that Organometallic Palladium catalyzes and synthesizes elagolix intermediate
CN105646285B (en) One kind dimension Lactel sieve intermediate and its preparation method and application
CN113475739A (en) Preparation method of S-nicotine
CN108299216A (en) The preparation method of 2,6- of one kind dimethyl-l-tyrosine
CN115536555B (en) 1, 2-Bis (2- (3, 5-dimethyl-4-nitriloxyphenoxy) ethoxy) ethane compound
CN113336764B (en) Bipyridine ligand with axial chirality and synthetic method thereof
CN103254087A (en) Preparation method of efavirenz intermediate
CN109942446A (en) A kind of preparation method of Pregabalin
CN107400083A (en) A kind of preparation method of 3 [2 (3 chlorphenyl) ethyl] 2 pyridine carbonitriles
CN107827844A (en) A kind of method for synthesizing butyrolactone derivative
CN108586427B (en) Preparation method of atorvastatin calcium intermediate
CN106946724A (en) The synthetic method of the benzyl malonic acid mono ethyl ester of 2 acetylamino of monoamine base inhibitor class intermediate 2
CN104557573B (en) The preparation method of (1S) 4,5 dimethoxy 1 [(methylamino) methyl] benzocyclobutane hydrochloride
CN107827845A (en) A kind of method of new synthesis butyrolactone derivative
CN116003299B (en) Difunctional nitrile oxide, preparation method and application thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WW01 Invention patent application withdrawn after publication
WW01 Invention patent application withdrawn after publication

Application publication date: 20180216